ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Astellas will acquire the bioelectronics start-up Iota Biosciences for $127.5 million and up to $176.5 million in milestone payments. Iota is developing millimeter-sized bioelectronic devices, called neural dust. Wirelessly powered by ultrasound, the devices and could be implanted to monitor or stimulate nerves. The firm was founded in 2017 by University of California, Berkeley, engineers Michel Maharbiz and Jose Carmena. Astellas says it will invest $125 million in Iota’s technology over 5 years.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter